Related Experiment Video
Updated: Oct 17, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Impact of COVID-19 on dermatologic surgery: experience of a Midwestern academic practice
Remi Hamel1, Bruin Pollard2, M Laurin Council3
1Division of Dermatology, Department of Medicine, Washington University School of Medicine, 660 South Euclid Avenue, Saint Louis, MO, 63110, USA.
Abstract:
The novel coronavirus disease 2019 (COVID-19) pandemic has disrupted clinical practice everywhere. The aim of this study was to quantify the specific impact of COVID-19 on skin cancer treatment at an academic dermatologic surgery practice. We conducted a retrospective chart review to compare metrics such as patient visits, histological upgrading, and Mohs stages per tumor between 60-day periods immediately before and after COVID-19 was declared a pandemic. Out of 1138 total encounters, decreases of 58% in total in-person visits and 38% in Mohs surgeries performed were observed following declaration of the pandemic. More squamous cell carcinoma and squamous cell carcinoma in situ (SCC/SCCIS) and less basal cell carcinoma (BCC) tumors were treated post-declaration compared to pre-declaration. There was a significantly higher histological upgrade rate for total tumors, as well as for the BCC subgroup, but not the SCC/SCCIS subgroup. While the overall number of dermatologic surgeries decreased after declaration of the pandemic, the higher histological upgrade rate reflects an appropriate triage of higher risk skin cancers. These findings may be useful both to assess the effectiveness of protocols for COVID-19 and to prepare for future resource-limited scenarios.
Insights
The COVID-19 pandemic reduced skin cancer surgeries by 38%, but higher upgrade rates for basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) indicate appropriate patient triage during this disruption.
Area of Science:
- Dermatology
- Surgical Oncology
- Public Health
Background:
- The COVID-19 pandemic significantly disrupted global healthcare delivery.
- Academic dermatologic surgery practices experienced unprecedented operational challenges.
Purpose of the Study:
- To quantify the impact of the COVID-19 pandemic on skin cancer treatment.
- To analyze changes in patient visits, surgical procedures, and tumor characteristics.
Main Methods:
- Retrospective chart review of 1138 patient encounters.
- Comparison of 60-day periods before and after the COVID-19 pandemic declaration.
- Analysis of in-person visits, Mohs surgeries, histological upgrading, and tumor types (BCC, SCC/SCCIS).
Main Results:
- A 58% decrease in total in-person visits and a 38% decrease in Mohs surgeries were observed post-pandemic declaration.
- Treatment shifted towards more squamous cell carcinoma (SCC/SCCIS) and less basal cell carcinoma (BCC).
- Histological upgrade rates increased significantly for all tumors and for BCC, but not SCC/SCCIS.
Conclusions:
- The pandemic led to reduced skin cancer surgeries but a higher rate of histological upgrades, suggesting effective risk-based patient prioritization.
- Findings offer insights into managing future public health crises in surgical dermatology.
- Protocols for COVID-19 demonstrated a capacity for adapting to resource limitations.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Peripheral Artery Disease V: Postoperative Nursing Management
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
